Search
Now showing items 1-10 of 17
Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients
Greiner, Jochen et al. (2021)
Wissenschaftlicher Artikel
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin
Schmalbrock, Laura K. et al. (2021)
Wissenschaftlicher Artikel
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
DiNardo, Courtney D. et al. (2021)
Wissenschaftlicher Artikel
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
DiNardo, Courtney D. et al. (2021)
Wissenschaftlicher Artikel
Deregulated expression of circular RNAs in acute myeloid leukemia
Lux, Susanne et al. (2021)
Wissenschaftlicher Artikel
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
Roboz, Gail J. et al. (2021)
Wissenschaftlicher Artikel
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
Heuser, Michael et al. (2021)
Wissenschaftlicher Artikel
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Rautenberg, Christina et al. (2021)
Wissenschaftlicher Artikel
Towards precision medicine for AML
Döhner, Hartmut; Wei, Andrew H.; Löwenberg, Bob (2021)
Wissenschaftlicher Artikel
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Duy, Cihangir et al. (2021)
Wissenschaftlicher Artikel